Skip to main content
HRES 709 113th Congress House Health Advanced technology and technological innovations Biological and life sciences Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Food and Drug Administration (FDA) Health programs administration and funding Health technology, devices, supplies Medical research Research administration and funding Research and development

Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a…

Show full title

Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.

Introduced: July 31, 2014 Introduced by: Vargas, Juan Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This resolution expired with the 113th Congress
It was not agreed to before the 113th Congress (2013–2014) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Agreed to (House)
Aug 1, 2014
Referred to the Subcommittee on Health.
Jul 31, 2014
Referred to the House Committee on Energy and Commerce.
Jul 31, 2014
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Recognizes the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and ways those challenges can be addressed.

What's happening now August 1, 2014

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 2
D
Peters, Scott H.
California · Sep 17, 2014
Denham, Jeff
· Jul 31, 2014
 D
Matsui, Doris O.
California · Jul 31, 2014
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 709: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.. 113th Congress. Open America. https://openamerica.io/bill/113-HRES-709/
MLA
"H. Res. 709: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HRES-709/.
Bluebook (legal)
H. Res. 709, 113th Cong. (2026), https://openamerica.io/bill/113-HRES-709/.
Markdown link
[H. Res. 709: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.](https://openamerica.io/bill/113-HRES-709/)
Report a problem